|
|
||||||||


1 Neotropix, Inc., 351 Phoenixville Pike, Malvern, PA 19355, USA
2 Institute for Animal Health, Pirbright Laboratory, Ash Road, Pirbright, Woking GU24 0NF, UK
3 Human Genome Sciences, 9920 Belward Campus Dr., Rockville, MD 20850, USA
4 MedImmune, Inc., One MedImmune Way, Gaithersburg, MD 20878, USA
Correspondence
Paul L. Hallenbeck
phallenbeck{at}neotropix.com
| ABSTRACT |
|---|
|
|
|---|
These authors contributed equally to this paper. ![]()
The GenBank/EMBL/DDBJ accession number for the complete genome sequence of SVV-001 is DQ641257.
| INTRODUCTION |
|---|
|
|
|---|
Here, we report the discovery and genetic analysis of the complete genome of a novel picornavirus, Seneca Valley virus isolate 001 (SVV-001), and propose that it be designated the prototype species in a novel genus, Senecavirus, in the family Picornaviridae. The complete genome sequence analysis of SVV-001 presented here supports the classification of the virus as a picornavirus, with the most closely related members of the family being cardioviruses.
| METHODS |
|---|
|
|
|---|
Electron microscopy.
Purified SVV-001 was mounted onto carbon-coated Formvar grids by using the direct application method, stained with uranyl acetate and visualized with a JEOL 1200 EX transmission electron microscope (Electron Microscopy BioServices). Additionally, PER.C6 cells were infected with SVV-001 at an m.o.i. of 100 and infected cells were collected at 2, 4, 8, 24 and 36 h post-infection. The cells were stained en bloc with 2 % aqueous uranyl acetate, dehydrated in a graded ethanol series and infiltrated and embedded in Spurr's plastic resin. The samples were allowed to polymerize overnight at 70 °C. Ultrathin sections, 60–80 nm in thickness, of SVV-001-infected PER.C6 cells were cut from embedded blocks and mounted onto 200-mesh copper grids. The grids were then post-stained with uranyl acetate and Reynolds' lead citrate (Reynolds, 1963
) and examined by using a JEOL 1200 EX transmission electron microscope. Representative micrographs were taken at x10 000–25 000 magnifications.
SDS-PAGE and N-terminal sequence analyses.
Purified SVV-001 was subjected to electrophoresis using a 10 % NuPAGE pre-cast Bis–Tris polyacrylamide mini-gel electrophoresis system (Novex). Half of the gel was visualized by silver staining using a Dodeka silver stain kit (Bio-Rad), whilst the other half was used to prepare samples for amino acid sequencing of the amino (N) termini of the capsid proteins. Prior to transfer of proteins to membranes, the gel was soaked in 10 mM N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) buffer, pH 11, for 1 h, and a PVDF membrane (GE Healthcare) was wetted in methanol. Proteins were then transferred to the PVDF membrane. After transfer, proteins were visualized by staining with Amido black for approximately 1 min, and bands of interest were excised with a scalpel and air-dried. The proteins were subjected to automated N-terminal sequence determination by Edman degradation using a pulsed-phase sequencer. The N-terminal sequences of the three viral proteins were subjected to similarity searches using the BLAST program at the National Center for Biotechnology Information (NCBI) website (http://www.ncbi.nlm.nih.gov/BLAST/).
Genome analysis of SVV-001.
The genomic RNA of SVV-001 was extracted by using TRIzol reagent (Invitrogen). Briefly, 250 µl purified virus (approx. 2.5x1013 virus particles) was mixed with 3 vols TRIzol and 240 µl chloroform. The RNA present in the aqueous phase was precipitated by adding 600 µl 2-propanol. An aliquot of RNA was resolved on a 1.25 % denaturing agarose gel and the band was visualized by ethidium bromide staining (data not shown). Synthesis of SVV-001 cDNA was performed under standard conditions using 1 µg RNA along with random 14-mer oligonucleotides, oligo-dT or viral-specific primers, and avian myeloblastosis virus reverse transcriptase, Thermo-X (Invitrogen) or the Transcriptor Reverse Transcriptase system (Roche Applied Science). DNA sequences of cDNA subclones in pCRII (Invitrogen) or of PCR products were determined at Lofstrand Laboratories (Gaithersburg, MD, USA), Commonwealth Biotechologies Inc. (Richmond, VA, USA) or Cleveland Genomics (Cleveland, OH, USA). The 5' end of the genome was cloned by using PCR with degenerate oligonucleotides encoding 5' sequences with similarities to cardiovirus sequences. Sequence data were compiled to generate the complete genome sequence of SVV-001 and were then analysed by using sequence-analysis programs [Clone Manager (Sci Ed Software), Vector NTI (Invitrogen) and Lasergene (DNASTAR)]. The predicted amino acid sequence was compared with entries in the NCBI protein sequence database by using BLAST.
Secondary-structure predictions.
The program PSIPRED v. 2.5 (Jones, 1999
) was used to predict the secondary structures of SVV-001 and other picornavirus 2B proteins. The program MEMSAT3 (Jones et al., 1994
), run from the PSIPRED protein structure prediction server (McGuffin et al., 2000
; http://bioinf.cs.ucl.ac.uk/psipred/), was used to predict transmembrane topology of the 3A polypeptides of SVV-001, encephalomyocarditis virus (EMCV) and Theiler's murine encephalomyelitis virus (TMEV).
Phylogenetic analysis.
The program SimPlot v. 3.5.1 (Lole et al., 1999
) was used to compare the genomes of SVV-001 and other cardioviruses. The following parameters were used: window, 200 bp; step, 20 bp; GapStrip, on; Kimura (2-parameter); T/t ratio, 2.0. The GenBank accession numbers of the sequences used in this analysis were EMCV-R (M81861
[GenBank]
), EMCV-Mengo (L22089
[GenBank]
), TMEV-GDVII (M20562
[GenBank]
), Theiler-like virus (TLV) of rats NGS910 (AB090161
[GenBank]
) and Saffold virus (SAF-V; EF165067
[GenBank]
). For this analysis, the entire genome was used except for the 5' UTR sequences upstream of the EMCV poly(C) tract, as the alignments are poor in this region. The programs BioEdit v7.0.1 (Hall, 1999
) and CLUSTAL X v. 1.83 (Thompson et al., 1997
) were used to compile the alignments of SVV-001 sequences with those of other viruses. Phylogenetic analyses were conducted by using MEGA version 3.1 (Kumar et al., 2004
). Mid-point-rooted neighbour-joining trees (Saitou & Nei, 1987
) were constructed by using an amino acid difference matrix based on a Poisson-corrected distance. Confidence levels on branches were estimated by bootstrap resampling using 1000 pseudoreplicates.
| RESULTS |
|---|
|
|
|---|
Sequencing of SVV-001
The complete nucleotide sequence of the SVV-001 genome was determined from several overlapping cDNA clones. However, the first 10 nt at the 5' end were derived cardiovirus consensus sequence and do not necessarily represent the actual 5'-end sequence of SVV. The RNA genome of SVV-001 consists of 7280 nt, excluding a 3' poly(A) tail, and has a G+C content of 51.6 mol%, a 666 nt 5' UTR and a shorter 3' UTR (71 nt). The organization of SVV-001 genome was determined by alignment of its nucleotide sequence and deduced amino acid sequence of the open reading frame (ORF) with those of other picornaviruses (data not shown). This analysis revealed a large, single ORF with the potential to encode a polyprotein precursor of 2181 aa. The genomic features of SVV-001 are related most closely to those of members of the genus Cardiovirus (Table 1
; Fig. 1
; and discussed below).
|
|
|
Folding of the 3' UTR of SVV revealed two stem–loops with the potential to form a kissing-loop structure (Fig. 3
). This type of structure has been shown to be important in enterovirus replication (Mirmomeni et al., 1997
).
|
|
P (Donnelly et al., 2001
The sizes of the predicted polypeptides of SVV-001 were then compared with those of two members of the cardioviruses, EMCV and TMEV (Fig. 1
), the most noticeable difference being the size of the 2A protein; the SVV-001 2A was considerably smaller than that of EMCV or TMEV.
Leader protein
The only picornaviruses to possess leader polypeptides preceding the capsid region are members of the genera Cardiovirus, Aphthovirus, Erbovirus, Kobuvirus, Teschovirus and the proposed genus Sapelovirus. In aphthoviruses and erboviruses, the leader proteins are papain-like cysteine proteinases that are able both to self-cleave carboxy-terminally and also to cleave the eukaryotic initiation factors (eIF) 4GI and 4GII, leading to shut-off of host-cell protein synthesis (Devaney et al., 1988
; Gradi et al., 2004
). The cardiovirus leader polypeptide binds zinc, is phosphorylated during infection and plays a role in the regulation of viral genome translation (Dvorak et al., 2001
). The functions of the kobuvirus, teschovirus and sapelovirus leaders are not known. The SVV-001 leader polypeptide lacks the catalytic residues necessary for proteolytic activity and does not contain either a zinc-finger motif [C-x-H-x(6)-C-x(2)-C] in the leader amino-terminal region or a tyrosine-phosphorylation motif [K-x(2)-E-x(2)-Y] approximately 14 residues downstream, possibly indicating a function distinct from that of leader peptides of aphthoviruses/erboviruses and cardioviruses.
The P1 region proteins
In picornaviruses, the P1 polypeptide is cleaved by the 3C protease to give VP0, VP3 and VP1. Sixty copies of these three polypeptides form the capsid. In most picornaviruses (the exceptions being parechoviruses, kobuviruses, duck hepatitis virus 1 and seal picornavirus), a maturation cleavage of VP0 occurs to give VP2 and the internally located VP4 (reviewed by Leong et al., 2002
). The capsid proteins of SVV-001 were all similar in size to those of cardioviruses (Fig. 1
), and a VP0 maturation cleavage was predicted to occur.
The P2 region proteins
The 2A protein in cardioviruses performs two distinct functions. One is a ribosome-skipping function to enable P1–2A to be separated from the elongating polyprotein (at the conserved NPG
P motif), and the second is inhibition of cap-dependent mRNA translation (Aminev et al., 2003a
) and cellular mRNA transcription (but not rRNA transcription) (Aminev et al., 2003b
). Notably, the 2A protein of SVV-001 is significantly different in size from those of cardioviruses. The cardioviruses have a long (approx. 150 aa) 2A protein, whereas SVV-001 is predicted to have a short (9 aa) 2A protein (discussed below). Thus, the 2A protein of SVV-001 would be predicted to perform only the P1–2A/2BC–P3 ribosome-skipping function. This is also the case in aphthoviruses, erboviruses and teschoviruses, which have very short 2A sequences ending in NPG
P. It is also possible that the 2A protein of SVV-001 could remain attached to the carboxy terminus of VP1, as it probably does in another picornavirus, Ljungan virus (Johansson et al., 2002
). However, unlike SVV-001, Ljungan virus has a second 2A polypeptide of different function immediately downstream of VP1.
The 2B protein of poliovirus is a viroporin that functions to enhance membrane permeability and plays a role in the formation of intracellular virus replication vesicles (Agirre et al., 2002
). The 2B protein of SVV-001 had no primary sequence similarity to those of other known picornaviruses. The secondary structures of the 2B proteins of representatives of all of the picornavirus genera, including SVV-001, were predicted by using the PSIPRED server (data not shown). This analysis revealed that, despite being very different in primary sequences, all picornavirus 2B proteins may be very similar in their secondary structure, being composed almost exclusively of helix–coil–helix structures, consistent with their possible role as viroporins.
The 2C protein is a helicase-like polypeptide involved in RNA synthesis (Gorbalenya et al., 1990
; Tanner & Linder, 2001
). The Hel-like domains of all picornaviruses viruses fall into superfamily III and contain motif A [GxxGxGK(S/T)], followed about 35 aa downstream by motif B (

xxDD, where
is any hydrophobic residue), and about 30 aa downstream of motif B by motif C [Kgxx
xSx

x(S/T)(S/T)N]. In SVV-001, these motifs are represented by GKPGCGKS, FVTLMDD and KGRPFTSNLIIATTN, with spacing of 36 and 32 aa, respectively.
The P3 region proteins
Little is known about the function of the 3A polypeptide; however, all picornavirus 3A proteins contain a putative transmembrane
-helix, which is characterized by a region of high hydrophobicity (aa 41–62 in SVV-001). Primary sequence identity between SVV-001 and cardioviruses is low for this protein; however, the 3A polypeptides are predicted to be of similar lengths and the putative transmembrane
-helix lies in the same region of the protein of SVV-001 compared with those of cardioviruses (data not shown).
The genome-linked polypeptide, VPg, which is encoded by the 3B region, shares few amino acids in common with the other picornaviruses; however, the third residue is a tyrosine, consistent with its linkage to the 5' end of the virus genome (Rothberg et al., 1978
).
The picornavirus 3C proteinase is a chymotrypsin-like enzyme with a cysteine in place of a serine in the catalytic site (Gorbalenya et al., 1986
; Bazan & Fletterick, 1988
). A catalytic triad (Bazan & Fletterick, 1988
) is made up of a histidine (SVV H3C48), an aspartate/glutamate (SVV D3C84) and the conserved cysteine (SVV C3C160). The catalytic cysteine is typically followed 10–20 aa downstream by a G
H motif (SVV GLH3C176–178) that seems to be involved in substrate recognition. The active-site residues have been confirmed by analysis of the known three-dimensional structures of 3C in other picornaviruses [HAV, Allaire et al., 1994
; Bergmann et al., 1997
; PV-1, Mosimann et al., 1997
; human rhinovirus (HRV)-14, Matthews et al., 1994
; HRV-2, Matthews et al., 1999
)]. The active-site residues are conserved in the 3C sequence of SVV-001 and all other known picornaviruses.
The 3D polypeptide interacts with the 3AB protein and can also act as a component of the 3CD protein. As such, it functions in virus replication and VPg uridylylation, and is the major component of the RNA-dependent RNA polymerase (RdRp). SVV-001 contains amino acid motifs conserved in the 3D protein of picornaviruses, i.e. KDEL/IR, PSG, YGDD and FLKR (Argos et al., 1984
).
Phylogenetic comparison of SVV-001 polypeptides with those of other picornaviruses
Those SVV-001 polypeptides that could be aligned with those of the cardioviruses (P1, 2C, 3C and 3D) were compared with the same proteins of representative members of each of the picornavirus species. Distance matrices and unrooted neighbour-joining trees were constructed and confidence limits on branches were accessed by bootstrap resampling (1000 pseudoreplicates). Phylogenetic trees comparing the P1, 2C, 3C and 3D polypeptides of SVV-001 with those of other representative picornaviruses show that, whilst SVV-001 is clearly different from EMCV and theiloviruses, it is related most closely to the members of the genus Cardiovirus (Fig. 4
).
|
| DISCUSSION |
|---|
|
|
|---|
The complete genome sequence of SVV-001 was determined and was shown to have a typical picornavirus L-4-3-4 genome layout. The principal genome regions that are conserved well enough across all of the picornaviruses to allow a meaningful phylogeny to be constructed are the IRES, P1, 2C, 3C and 3D regions. Other genome regions are often very different between genera and sometimes even between virus species. Comparisons with other picornaviruses showed that the P1, 2C, 3C and 3D polypeptides of SVV-001 were related most closely to those of the cardioviruses, whilst other regions differed considerably from those of all other picornaviruses. In the non-structural polypeptides 2C, 3C and 3D, which are generally considered to be relatively conserved in picornaviruses, SVV-001 is also related most closely to the cardioviruses, although it is not related as closely to EMCV and TMEV as they are to each other. SVV-001 diverges greatly from the cardioviruses in the 2B and 3A polypeptides and has no detectable relationship with any known picornavirus in these regions. Recently, these types of difference have been used to propose that avian encephalomyelitis virus (AEV), currently assigned to the genus Hepatovirus (Marvil et al., 1999
), be classified in a novel genus, provisionally named Tremovirus (http://www.picornastudygroup.com/).
Several characteristics of SVV-001 differ from those of cardioviruses: (i) the SVV-001 IRES appears to be type IV, not type II like cardiovirus IRES sequences (Hellen & de Breyne, 2007
); (ii) the cardioviruses have a long (150 aa) 2A protease, whereas that of SVV-001 is predicted to be much shorter (9 aa), if it is indeed cleaved from VP1; and (iii) the amino acid sequences of the leader, 2B and 3A polypeptides do not share sequence similarity with those of cardioviruses. In FMDV and human rhinoviruses, these proteins have been shown to be involved in host-cell tropism and virulence (Lomax & Yin, 1989
; Beard & Mason, 2000
; Knowles et al., 2001
; Pacheco et al., 2003
; Harris & Racaniello, 2005
).
The complete genome sequence and phylogenetic analyses assume significance in the light of recent findings that the virus has very potent oncolytic properties. In vitro and in vivo studies of the virus revealed its tropism towards tumour cells with neuroendocrine properties (Reddy et al., 2007
). Currently, the virus is being evaluated in phase I clinical trials for treatment of neuroendocrine cancers. A few other members of the family Picornaviridae have been found to possess cell-killing activity against certain human cancers (Au et al., 2005
; Shafren et al., 2005
; Adachi et al., 2006
; Ochiai et al., 2006
; Toyoda et al., 2007
).
The data presented here demonstrate clearly that SVV-001 is a member of the family Picornaviridae and is related most closely to, but differs from, members of the genus Cardiovirus. Recognizing the unique properties of SVV-001, the Picornaviridae Study Group (PSG) recommended that the virus be classified as a novel species, Seneca Valley virus, placed in a novel picornavirus genus, Senecavirus (http://www.picornastudygroup.com/). The taxonomic position of SVV-001 within the family Picornaviridae will be decided by the International Committee on Taxonomy of Viruses (ICTV) following recommendations by the PSG and supporting published material.
| ACKNOWLEDGEMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Agirre, A., Barco, A., Carrasco, L. & Nieva, J. L. (2002). Viroporin-mediated membrane permeabilization. Pore formation by nonstructural poliovirus 2B protein. J Biol Chem 277, 40434–40441.
Allaire, M., Chernaia, M. M., Malcolm, B. A. & James, M. N. (1994). Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. Nature 369, 72–76.[CrossRef][Medline]
Aminev, A. G., Amineva, S. P. & Palmenberg, A. C. (2003a). Encephalomyocarditis viral protein 2A localizes to nucleoli and inhibits cap-dependent mRNA translation. Virus Res 95, 45–57.[CrossRef][Medline]
Aminev, A. G., Amineva, S. P. & Palmenberg, A. C. (2003b). Encephalomyocarditis virus (EMCV) proteins 2A and 3BCD localize to nuclei and inhibit cellular mRNA transcription but not rRNA transcription. Virus Res 95, 59–73.[CrossRef][Medline]
Argos, P., Kamer, G., Nicklin, M. J. & Wimmer, E. (1984). Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res 12, 7251–7267.
Au, G. G., Lindberg, A. M., Barry, R. D. & Shafren, D. R. (2005). Oncolysis of vascular malignant human melanoma tumors by coxsackievirus A21. Int J Oncol 26, 1471–1476.[Medline]
Bazan, J. F. & Fletterick, R. J. (1988). Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proc Natl Acad Sci U S A 85, 7872–7876.
Beard, C. W. & Mason, P. W. (2000). Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol 74, 987–991.
Bergmann, E. M., Mosimann, S. C., Chernaia, M. M., Malcolm, B. A. & James, M. N. G. (1997). The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition. J Virol 71, 2436–2448.[Abstract]
Brown, E. A., Zhang, H., Ping, L. H. & Lemon, S. M. (1992). Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 20, 5041–5045.
Devaney, M. A., Vakharia, V. N., Lloyd, R. E., Ehrenfeld, E. & Grubman, M. J. (1988). Leader protein of foot-and-mouth-disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol 62, 4407–4409.
Donnelly, M. L., Luke, G., Mehrotra, A., Li, X., Hughes, L. E., Gani, D. & Ryan, M. D. (2001). Analysis of the aphthovirus 2A/2B polyprotein cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal skip'. J Gen Virol 82, 1013–1025.
Dvorak, C. M., Hall, D. J., Hill, M., Riddle, M., Pranter, A., Dillman, J., Deibel, M. & Palmenberg, A. C. (2001). Leader protein of encephalomyocarditis virus binds zinc, is phosphorylated during viral infection, and affects the efficiency of genome translation. Virology 290, 261–271.[CrossRef][Medline]
Fallaux, F. J., Bout, A., van der Velde, I., van den Wollenberg, D. J., Hehir, K. M., Keegan, J., Auger, C., Cramer, S. J., van Ormondt, H. & other authors (1998). New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 9, 1909–1917.[Medline]
Gorbalenya, A. E., Blinov, V. M. & Donchenko, A. P. (1986). Poliovirus-encoded proteinase 3C: a possible evolutionary link between cellular serine and cysteine proteinase families. FEBS Lett 194, 253–257.[CrossRef][Medline]
Gorbalenya, A. E., Koonin, E. V. & Wolf, Y. I. (1990). A new superfamily of putative NTP-binding domains encoded by genomes of small DNA and RNA viruses. FEBS Lett 262, 145–148.[CrossRef][Medline]
Gradi, A., Foeger, N., Strong, R., Svitkin, Y. V., Sonenberg, N., Skern, T. & Belsham, G. J. (2004). Cleavage of eukaryotic translation initiation factor 4GII within foot-and-mouth disease virus-infected cells: identification of the L-protease cleavage site in vitro. J Virol 78, 3271–3278.
Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41, 95–98.
Harris, J. R. & Racaniello, V. R. (2005). Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells. J Virol 79, 5363–5373.
Hellen, C. U. T. & de Breyne, S. (2007). A distinct group of hepacivirus/pestivirus-like internal ribosome entry sites in members of diverse Picornavirus genera: evidence for modular exchange of functional noncoding RNA elements by recombination. J Virol 81, 5850–5863.
Johansson, S., Niklasson, B., Maizel, J., Gorbalenya, A. E. & Lindberg, A. M. (2002). Molecular analysis of three Ljungan virus isolates reveals a new, close-to-root lineage of the Picornaviridae with a cluster of two unrelated 2A proteins. J Virol 76, 8920–8930.
Jones, D. T. (1999). Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 292, 195–202.[CrossRef][Medline]
Jones, D. T., Taylor, W. R. & Thornton, J. M. (1994). A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 33, 3038–3049.[CrossRef][Medline]
Kapoor, A., Victoria, J., Simmonds, P., Wang, C., Shafer, R. W., Nims, R., Nielsen, O. & Delwart, E. (2008). A highly divergent picornavirus in a marine mammal. J Virol 82, 311–320.
Knowles, N. J., Davies, P. R., Henry, T., O'Donnell, V., Pacheco, J. M. & Mason, P. W. (2001). Emergence in Asia of foot-and-mouth disease viruses with altered host range: characterization of alterations in the 3A protein. J Virol 75, 1551–1556.
Krumbholz, A., Dauber, M., Henke, A., Birch-Hirschfeld, E., Knowles, N. J., Stelzner, A. & Zell, R. (2002). Sequencing of porcine enterovirus groups II and III reveals unique features of both virus groups. J Virol 76, 5813–5821.
Kumar, S., Tamura, K. & Nei, M. (2004). MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5, 150–163.
Leong, L. E.-C., Cornell, C. T. & Semler, B. L. (2002). Processing determinants and functions of cleavage products of picornavirus polyproteins. In Molecular Biology of Picornaviruses, pp. 187–197. Edited by B. L. Semler & E. Wimmer. Washington, DC: American Society for Microbiology.
Lole, K. S., Bollinger, R. C., Paranjape, R. S., Gadkari, D., Kulkarni, S. S., Novak, N. G., Ingersoll, R., Sheppard, H. W. & Ray, S. C. (1999). Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73, 152–160.
Lomax, N. B. & Yin, F. H. (1989). Evidence for the role of the P2 protein of human rhinovirus in its host range change. J Virol 63, 2396–2399.
Marvil, P., Knowles, N. J., Mockett, A. P. A., Britton, P., Brown, T. D. K. & Cavanagh, D. (1999). Avian encephalomyelitis virus is a picornavirus and is most closely related to hepatitis A virus. J Gen Virol 80, 653–662.[Abstract]
Matthews, D. A., Smith, W. W., Ferre, R. A., Condon, B., Budahazi, G., Sisson, W., Villafranca, J. E., Janson, C. A., McElroy, H. E. & other authors (1994). Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 77, 761–771.[CrossRef][Medline]
Matthews, D. A., Dragovich, P. S., Webber, S. E., Fuhrman, S. A., Patick, A. K., Zalman, L. S., Hendrickson, T. F., Love, R. A., Prins, T. J. & other authors (1999). Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci U S A 96, 11000–11007.
Matzura, O. & Wennborg, A. (1996). RNAdraw: an integrated program for RNA secondary structure calculation and analysis under 32-bit Microsoft Windows. Comput Appl Biosci 12, 247–249.
McGuffin, L. J., Bryson, K. & Jones, D. T. (2000). The PSIPRED protein structure prediction server. Bioinformatics 16, 404–405.
Mirmomeni, M. H., Hughes, P. J. & Stanway, G. (1997). An RNA tertiary structure in the 3' untranslated region of enteroviruses is necessary for efficient replication. J Virol 71, 2363–2370.[Abstract]
Mosimann, S. C., Cherney, M. M., Sia, S., Plotch, S. & James, M. N. (1997). Refined X-ray crystallographic structure of the poliovirus 3C gene product. J Mol Biol 273, 1032–1047.[CrossRef][Medline]
Oberste, M. S., Maher, K. & Pallansch, M. A. (2003). Genomic evidence that simian virus 2 and six other simian picornaviruses represent a new genus in Picornaviridae. Virology 314, 283–293.[CrossRef][Medline]
Ochiai, H., Campbell, S. A., Archer, G. E., Chewning, T. A., Dragunsky, E., Ivanov, A., Gromeier, M. & Sampson, J. H. (2006). Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus. Clin Cancer Res 12, 1349–1354.
Pacheco, J. M., Henry, T. M., O'Donnell, V. K., Gregory, J. B. & Mason, P. W. (2003). Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus. J Virol 77, 13017–13027.
Reddy, P. S., Burroughs, K. D., Hales, L. M., Ganesh, S., Jones, B. H., Idamakanti, N., Hay, C., Li, S. S., Skele, K. L. & other authors (2007). Seneca Valley virus: a systemically deliverable oncolytic picornavirus for the treatment of neuroendocrine cancers. J Natl Cancer Inst 99, 1623–1633.
Reynolds, E. S. (1963). The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17, 208–212.
Rothberg, P. G., Harris, T. J., Nomoto, A. & Wimmer, E. (1978). O4-(5'-uridylyl) tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A 75, 4868–4872.
Saitou, N. & Nei, M. (1987). The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4, 406–425.[Abstract]
Scraba, D. G. & Palmenberg, A. C. (1999). Cardioviruses (Picornaviridae). In Encyclopedia of Virology, 2nd edn, pp. 1–10. Edited by R. G. Webster & A. Granoff. San Diego, CA: Academic Press.
Shafren, D. R., Sylvester, D., Johansson, E. S., Campbell, I. G. & Barry, R. D. (2005). Oncolysis of human ovarian cancers by echovirus type 1. Int J Cancer 115, 320–328.[CrossRef][Medline]
Stanway, G., Brown, F., Christian, P., Hovi, T., Hyypiä, T., King, A. M. Q., Knowles, N. J., Lemon, S. M., Minor, P. D. & other authors (2005). Family Picornaviridae. In Virus Taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses, pp. 757–778. Edited by C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger & L. A. Ball. San Diego, CA: Elsevier/Academic Press.
Tanner, N. K. & Linder, P. (2001). DExD/H box helicases: from generic motors to specific dissociation functions. Mol Cell 8, 251–262.[CrossRef][Medline]
Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F. & Higgins, D. G. (1997). The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25, 4876–4882.
Toyoda, H., Yin, J., Mueller, S., Wimmer, E. & Cello, J. (2007). Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model. Cancer Res 67, 2857–2864.
Tseng, C. H. & Tsai, H. J. (2007). Sequence analysis of a duck picornavirus isolate indicates that it together with porcine enterovirus type 8 and simian picornavirus type 2 should be assigned to a new picornavirus genus. Virus Res 129, 104–114.[CrossRef][Medline]
Tseng, C. H., Knowles, N. J. & Tsai, H. J. (2007). Molecular analysis of type 1 duck hepatitis virus indicated that it should be assigned to a new genus. Virus Res 123, 190–203.[CrossRef][Medline]
Received 7 November 2007;
accepted 30 January 2008.
This article has been cited by other articles:
![]() |
A. Kapoor, J. Victoria, P. Simmonds, E. Slikas, T. Chieochansin, A. Naeem, S. Shaukat, S. Sharif, M. M. Alam, M. Angez, et al. A highly prevalent and genetically diversified Picornaviridae genus in South Asian children PNAS, December 23, 2008; 105(51): 20482 - 20487. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |